Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC reported 14 positions worth $251.8M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PCVX (32.2%). Biggest move: new buy OBX ($11.8M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | PCVX | $81.1M | 32.22% | 1,425,470 | — | — | +8.3% | |
| ▸ 2 | ARQT | $26.6M | 10.58% | 1,008,174 | — | — | +2.7% | |
| ▸ 3 | TRVI | $25.0M | 9.91% | 1,742,672 | — | — | -7.2% | |
| ▸ 4 | AVLN | $24.7M | 9.81% | 866,792 | — | — | +4.5% | |
| ▸ 5 | EVMN | $15.9M | 6.32% | 1,926,943 | — | — | -7.6% | |
| ▸ 6 | IMNM | $15.8M | 6.26% | 732,512 | — | — | -12.7% | |
| ▸ 7 | OCS | $15.5M | 6.15% | 1,658,907 | — | — | — | |
| ▸ 8 | OBX | $11.8M | 4.69% | 860,343 | — | — | — | |
| ▸ 9 | AVTX | $6.7M | 2.64% | 434,033 | — | — | -49.4% | |
| ▸ 10 | BRVE | $6.4M | 2.55% | 317,351 | — | — | -2.9% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Pivotal bioVenture Partners Investment Advisor LLC hold as of Q3 2026?
Pivotal bioVenture Partners Investment Advisor LLC reported 14 positions worth $251.8M in its Q3 2026 13F filing. Largest positions: PCVX (32.2%), ARQT (10.6%), TRVI (9.9%), AVLN (9.8%) and EVMN (6.3%).
What did Pivotal bioVenture Partners Investment Advisor LLC buy in Q3 2026?
New positions: OBX and BRVE. Added to: OCS.
What did Pivotal bioVenture Partners Investment Advisor LLC sell in Q3 2026?
Reduced: ZBIO, ARQT and AVLN. Sold out entirely: RXRX.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.